Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

GlobeNewswire EN Nachrichten

GlobeNewswire verbreitet Pressemeldungen und Pflichtmitteilungen von börsennotierten Gesellschaften. Der Großteil der Mitteilungen stammt von Unternehmen aus Nordamerika, Großbritannien und den nordeuropäischen Ländern.
 
02.03.26 - 06:03
U.S.–Iran Conflict Shakes Markets: TRWD Says Growth Strategy Remains Intact (GlobeNewswire EN)
 
U.S.–Iran conflict shakes markets as TRWD reaffirms $10M capital access and targets $40M revenue in domestic nightlife growth strategy....
02.03.26 - 06:03
Okeanis Eco Tankers Corp. – Ex Dividend Date (GlobeNewswire EN)
 
ATHENS, Greece, March 02, 2026 (GLOBE NEWSWIRE) -- Reference is made to the key information relating to Q4 2025 dividend announced by Okeanis Eco Tankers Corp. ("OET" or the "Company") (NYSE: ECO / OSE: OET) on February 18, 2026. The Company's common shares will be traded ex dividend USD 1.55 per common share on the Oslo Stock Exchange from today, March 2, 2026 and on the New York Stock Exchange from March 3, 2026....
02.03.26 - 03:06
InnoCare′s next-generation TRKi Zurletrectinib Receives Priority Review for the Treatment of Pediatric Patients with Solid Tumors in China (GlobeNewswire EN)
 
InnoCare's next-generation TRK inhibitor Zurletrectinib receives priority review for the treatment of pediatric patients with solid tumors in China....
02.03.26 - 02:03
PONY AI Inc. Achieved Gen-7 Robotaxi UE Breakeven in Shenzhen, Strengthening Path to Scalable Commercialization (GlobeNewswire EN)
 
SHENZHEN, China, March 02, 2026 (GLOBE NEWSWIRE) -- Pony AI Inc. (“Pony.ai” or the “Company”) (NASDAQ: PONY; HKEX: 2026), a global leader in achieving large-scale mass production and commercialization of autonomous driving technology, today announced that it has achieved seventh-generation (“Gen-7”) Robotaxi unit economics (“UE”) breakeven1 in Shenzhen. This milestone underscores Pony.ai's capability to realize a sustainable business model, laying a solid foundation to accelerate scale-up over a multi-year horizon....
02.03.26 - 00:33
Veea Platform Solution to Address Cybersecurity Challenges Nationwide for Businesses in Mexico (GlobeNewswire EN)
 
At Mobile World Congress 2026 in Barcelona, March 2-4, Veea will demonstrate a first-of-a-kind Plug-and-Play 5G FWA with AI-Enhanced Cybersecurity and Value-added Services At Mobile World Congress 2026 in Barcelona, March 2-4, Veea will demonstrate a first-of-a-kind Plug-and-Play 5G FWA with AI-Enhanced Cybersecurity and Value-added Services...
02.03.26 - 00:09
CORRECTION -- WeShop Helps Pet Lovers Turn Everyday Pet Spending into Ownership (GlobeNewswire EN)
 
WeShop Helps Pet Lovers Turn Everyday Pet Spending into Ownership with Chewy and PetSmart...
02.03.26 - 00:00
Investor Education Webinar (GlobeNewswire EN)
 
The Future of Prostate Imaging: What do physicians want? The Future of Prostate Imaging: What do physicians want?...
01.03.26 - 23:54
Closing date for director nominations (GlobeNewswire EN)
 
TORONTO and PERTH, Western Australia, March 01, 2026 (GLOBE NEWSWIRE) -- Cygnus Metals Limited (ASX:CY5) advises, in accordance with ASX Listing Rule 3.13.1, that the Annual General Meeting of the Company (“Meeting”) will be held in West Perth, Western Australia on Friday, 1 May 2026. Further details in respect of the Meeting will be provided in the Notice of Meeting to be dispatched to shareholders prior to the Meeting....
01.03.26 - 22:42
Avavav Turns the Runway Inside Out - and Oatly Pours it Forward (GlobeNewswire EN)
 
Where fashion performance meets oat drink innovation Where fashion performance meets oat drink innovation...
01.03.26 - 18:33
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity (GlobeNewswire EN)
 
-- -18.8% placebo-adjusted difference in BMI reduction achieved in all patients (N=142) at 52 weeks, including 12 Japanese patients and 10 supplemental patients with acquired hypothalamic obesity -- -- March 20, 2026 PDUFA goal date for sNDA for setmelanotide in acquired hypothalamic obesity --...
01.03.26 - 17:21
Apple iSports Signs Joint Venture Agreement with Apple iCasino (GlobeNewswire EN)
 
IRVINE, Calif., March 01, 2026 (GLOBE NEWSWIRE) -- Apple iSports (OTC-QB: AAPI) (“Company” or “Apple iSports” or “AiS”), a gaming, entertainment, and technology services company, is pleased to announce it has signed a Joint Venture Agreement (“Agreement “or “JV Agreement”) with AiC Enterprises LLC, Belize ("AiC"), a premier, online gaming company....
01.03.26 - 17:21
Apple iSports Group Appoints Ian Wilding as Fractional Chief Innovation Officer to Support Strategic Growth and Nasdaq Readiness (GlobeNewswire EN)
 
IRVINE, Calif., March 01, 2026 (GLOBE NEWSWIRE) -- Apple iSports (OTC-QB: AAPI) (“Company” or “Apple iSports” or “AiS”), a digital gaming, entertainment, and technology company, announced the appointment of Ian Wilding, Founder and CEO of Hangar 75, as Fractional Chief Innovation Officer....
01.03.26 - 15:48
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting (GlobeNewswire EN)
 
– Primary endpoint of endoscopic nasal polyp score (NPS) showed reduction of -1.95 (p < 0.0001) in new analysis with adjustment for concomitant rescue therapy use –...
01.03.26 - 15:48
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy (GlobeNewswire EN)
 
SEP-631 Demonstrated Robust, Dose-Dependent Inhibition of Icatibant-Induced Skin Wheal Formation, with Complete Inhibition Observed at Doses as Low as 10 mg Once-Daily ...
01.03.26 - 15:48
Celldex Presents Positive Data Demonstrating Barzolvolimab Retreatment Achieves Similar Profound Efficacy to First Exposure in Patients with Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Further Demonstrating First-in-Class and Best-in-Di (GlobeNewswire EN)
 
- Late breaking Poster Presentation at AAAAI -- Ability to retreat facilitates a real-world paradigm in which treatment for ColdU and SD may be intermittent with barzolvolimab -...
01.03.26 - 14:03
Nokia expands network portfolio for premium performance in the AI-RAN era #MWC26 (GlobeNewswire EN)
 
Nokia today announced a major evolution of its AirScale portfolio with the launch of Doksuri Remote Radio Heads (Radios)...
01.03.26 - 14:03
Nokia and Ericsson strengthen cooperation to accelerate towards Autonomous Networks (GlobeNewswire EN)
 
Nokia and Ericsson today announce a landmark collaboration aimed at significantly advancing intelligent automation...
01.03.26 - 14:03
Nokia accelerates AI-RAN momentum with new partnerships driving path to AI-Native 6G #MWC26 (GlobeNewswire EN)
 
Nokia announces significant progress in its strategic AI-RAN partnership with NVIDIA, including new customer integrations and successful functional tests...
01.03.26 - 08:33
NIO Inc. Provides February 2026 Delivery Update (GlobeNewswire EN)
 
SHANGHAI, March 01, 2026 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced its February 2026 delivery results....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Eine schöne Frau gehört der Welt, eine häßliche dir allein. - Sprichwort Indien
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!